FDA Adverse Event Malfunction Summary report: N

ACCESS® 2 IMMUNOASSAY SYSTEM

MDR report key: 1930952 · Received December 17, 2010

Report

Report Number
2122870-2010-00948
Event Type
Malfunction
Date Received
December 17, 2010
Date of Event
November 16, 2010
Report Date
November 17, 2010
Manufacturer
BECKMAN COULTER INC.
Product Code
JJE
PMA / PMN Number
K922823/A007
Removal / Correction Number
N/A
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

PRIOR TO RUNNING PATIENT SAMPLE, THE CUSTOMER REPORTED SMELLING AN ELECTRICAL BURNING SMELL. THE CUSTOMER WAS UNABLE TO DETERMINE WHERE THE SMELL WAS ORIGINATING. NO SMOKE OR FLAMES WERE REPORTED. A FIELD SERVICE ENGINEER (FSE) WAS DISPATCHED ON (B)(4) 2010. THE FSE INSPECTED THAT THE PRESSURE BOARD HAD SHORTED OUT AND WAS REPLACED. THE FSE ALSO REPLACED THE PERI-TUBING, INCUBATOR BELT AND CLIPS. A HIGH SENSITIVITY (HS) TEST AND QC WAS PERFORMED AND ALL TESTING PASSED WITHIN PUBLISHED SPECIFICATIONS. ALTHOUGH HARDWARE ISSUES WERE ADDRESSED, NO DEFINITIVE ROOT CAUSE WAS DETERMINED.

Description of Event or Problem · 1

A CUSTOMER CONTACTED BECKMAN COULTER INC. (BCI) IN REGARDS TO OBTAINING ERRONEOUSLY ELEVATED RESULTS FOR TROPONIN (ACCUTNI) RESULTS ABOVE THE AMI-CUTOFF ON ONE PATIENT'S SAMPLE GENERATED BY THE ACCESS 2 IMMUNOASSAY SYSTEM. THE CUSTOMER ALSO OBTAINED ERRONEOUSLY ELEVATED CREATININE KINASE - MB (CKMB) AND MYOGLOBIN RESULTS ABOVE THE NORMAL REFERENCE RANG EON THE SAME PATIENT'S SAMPLE. THE SAMPLE WAS SENT TO AN ALTERNATE LAB WHICH RECOVERED "NORMAL" RESULTS FOR ALL THREE ASSAYS. NO ERRONEOUS RESULTS WERE REPORTED OUT OF THE LABORATORY. THE CUSTOMER DID NOT RECEIVE ANY REPORT OF PATIENT INJURY REQUIRING MEDICAL INTERVENTION OR CHANGE TO PATIENT TREATMENT ATTRIBUTED OR CONNECTED WITH THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ACCESS® 2 IMMUNOASSAY SYSTEM DISCRETE PHOTOMETRIC CHEMISTRY ANALYZER JJE BECKMAN COULTER INC. ACCESS 2 N/A

Patients

Seq Age Sex Outcome Treatment
1